Remedy Q3 Revenue Surges 226% to €39.6m as Control Resonant Becomes Fastest-Selling Title

Key points

• Q3 revenue reached €39.6 million, up 226% from the previous year, with game sales and royalties totaling €35 million.
• Operating profit was €0.6 million, a significant improvement from the €16.4 million loss recorded in Q3 2025.
• Control Resonant sold over one million units by October 15, three weeks after its September 24 launch, making it Remedy's fastest-selling title.
• The US represented nearly half of PC and console sales, followed by Chinese-speaking regions and the UK on PC, and the UK, Canada, and Brazil on console.
• Nearly half of Control Resonant's players were new to the franchise, with 2.4 million outstanding wishlists indicating future potential.
• The original Control saw increased sales in Q3, outperforming the previous two quarters and the same period last year.

Background

Control Resonant launched in September 2026, marking Remedy's first self-published release of this scale. Prior to its launch, the game received an 83 Metacritic score and strong player ratings, though it was noted for having the lowest critical rating among the main Control and Alan Wake titles. The studio had previously reported a €16.4 million loss in Q3 2025, making the current return to profit a significant turnaround. The Max Payne 1 & 2 remake was first announced in 2022, with Rockstar Games serving as publisher and funder.

How outlets are covering it

Eurogamer emphasized the 226% revenue surge and the game's status as a 'defining milestone' for Remedy, highlighting the influx of new players. GamesIndustry.biz provided detailed breakdowns of regional sales and the €35 million in game sales and royalties, noting the impact of Annapurna's share. GameSpot focused on the return to profit and the 2.4 million wishlists as a foundation for future growth, while also mentioning the weaker performance of FBC: Firebreak. GameWatcher highlighted the post-launch development of Control Resonant and the production readiness of an unnamed new project, suggesting a possible return to the Alan Wake franchise. All outlets agreed on the strong commercial performance of Control Resonant, but differed in emphasis: Eurogamer and GamesIndustry.biz focused on financial metrics, GameSpot on long-term potential, and GameWatcher on future development pipeline.

Why it matters

The success of Control Resonant demonstrates Remedy's ability to expand its audience and return to profitability after a period of losses. The strong performance provides a solid foundation for future projects, including the Max Payne 1 & 2 remake and an unnamed new title. The game's success also validates Remedy's shift to self-publishing, allowing it to retain more revenue and control over its IP. The influx of new players suggests that the Control franchise has broader appeal than previously thought, potentially leading to increased sales for the original Control and other titles in the Remedy Connected Universe.

What to watch

Remedy will continue to invest in marketing and organic visibility for Control Resonant, aiming to convert the 2.4 million wishlists into sales. The company will also focus on post-launch development for Control Resonant and the production of an unnamed new project. The Max Payne 1 & 2 remake will remain in full production, with Rockstar Games likely to announce a release window after Grand Theft Auto VI. Sales over the remainder of 2026 will ultimately define the company's financial year, with Remedy aiming to maintain its momentum and expand its two core franchises, Control and Alan Wake.